0001062993-24-005969.txt : 20240308 0001062993-24-005969.hdr.sgml : 20240308 20240308161219 ACCESSION NUMBER: 0001062993-24-005969 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240306 FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boston Megan CENTRAL INDEX KEY: 0001808923 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39267 FILM NUMBER: 24734476 MAIL ADDRESS: STREET 1: LEVEL 14, 114 WILLIAM ST CITY: MELBOURNE, VIC STATE: C3 ZIP: 3000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Benitec Biopharma Inc. CENTRAL INDEX KEY: 0001808898 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3940 TRUST WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 780-0819 MAIL ADDRESS: STREET 1: 3940 TRUST WAY CITY: HAYWARD STATE: CA ZIP: 94545 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2024-03-06 0001808898 Benitec Biopharma Inc. BNTC 0001808923 Boston Megan C/O BENITEC BIOPHARMA INC. 3940 TRUST WAY HAYWARD CA 94545 1 1 0 0 Executive Director 0 Options (right to buy) 5.21 2024-03-06 4 A 0 200004 0 A 2034-03-06 Common Stock 200004 200004 D The stock options will vest in three substantially equal installments on March 6, 2025, March 6, 2026, and March 6, 2027. /s/ Megan Boston 2024-03-08